Advanced Biomed (ADVB) Cash from Financing Activities (2024 - 2026)
Advanced Biomed (ADVB) posted Cash from Financing Activities of $910034.0 for Q1 2026, up 378.91% sequentially from -$326280.0 in Q4 2025, and down 83.65% YoY from $5.6 million in Q1 2025.
Advanced Biomed (ADVB) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Advanced Biomed has reported Cash from Financing Activities for 3 years, with the latest figure at $910034.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 83.65% year-over-year to $910034.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $600429.0 (down 91.02% YoY) and the FY2025 annual result came in at $5.9 million, up 217.88% from the prior year.
- Cash from Financing Activities grew to $910034.0 in Q1 2026 per ADVB's latest filing, from -$326280.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $5.6 million in Q1 2025 and troughed at -$430787.0 in Q2 2025.
- A 3-year average of $872361.3 and a median of $408286.0 in 2024 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 889.73% in 2025, down 233.15% in 2025.
- Over 3 years, Cash from Financing Activities stood at $408286.0 in 2024, then sank by 179.91% to -$326280.0 in 2025, then jumped by 378.91% to $910034.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $910034.0, -$326280.0, and $447462.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 12.21 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -325.19 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -919.90 Mn |
| 10 | Advanced Biomed | 12.28 Mn | 12.28 Mn | - | 268,277.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 268,277.00 |
| Mar 31, 2026 | 268,277.00 |
| Dec 31, 2025 | 315,477.00 |
| Dec 31, 2025 | 315,477.00 |
| Sep 30, 2025 | 447,462.00 |
| Sep 30, 2025 | 447,462.00 |
| Jun 30, 2025 | -765,466.00 |
| Jun 30, 2025 | -765,466.00 |
| Mar 31, 2025 | 5.90 Mn |
| Mar 31, 2025 | 5.90 Mn |
| Dec 31, 2024 | 408,286.00 |
| Dec 31, 2024 | 408,286.00 |
| Sep 30, 2024 | 392,525.00 |
| Sep 30, 2024 | 392,525.00 |
| Jun 30, 2024 | 323,536.00 |
| Jun 30, 2024 | 323,536.00 |
| Mar 31, 2024 | 562,199.00 |
| Mar 31, 2024 | 562,199.00 |